Sidra Medicine and Great Ormond Street Hospital Launch Partnership for Pediatric Innovation

Strategic Insights -

Sidra Medicine, a member of Qatar Foundation, has taken a significant step in advancing pediatric care and innovation by signing a Memorandum of Understanding with Great Ormond Street Hospital for Children NHS Foundation Trust, one of the world's leading pediatric hospitals. The partnership aims to enhance treatment pathways for rare pediatric diseases, including the development and application of gene therapies. This collaboration will also improve joint capabilities in clinical trial design and implementation, driving progress in personalized pediatric medicine.

Key Takeaways:

  • The partnership between Sidra Medicine and Great Ormond Street Hospital will focus on collaboration across key areas of clinical service, research, and education in children's health.
  • The agreement outlines a multi-year framework aimed at advancing treatment pathways for rare pediatric diseases, including the development and application of gene therapies.
  • The partnership will create a coordinated referral system to facilitate timely access to advanced laboratory testing, ensuring specialized care for children with complex conditions, including genetic disorders and rare diseases.
  • The alliance will enhance joint capabilities in clinical trial design and implementation, driving progress in personalized pediatric medicine.
  • The partnership will roll out education and skills exchange initiatives to support the next generation of healthcare professionals, including international fellowships, observerships, and training programs.
  • Sidra Medicine's unique genetic data on Arab populations, combined with GOSH's advanced secure data environment, world-class clinical and research expertise, creates a powerful opportunity to develop region-specific diagnostic tools and clinical trials.
  • The partnership aligns with Sidra Medicine's Clinical Trials Program, which focuses on the development of effective treatments for pediatric rare diseases.
  • Dr. Iyabo Tinubu-Karch, CEO of Sidra Medicine, said: "Our MoU with Great Ormond Street Hospital reflects our forward-looking vision to integrate global expertise into localized care models."
  • Matthew Shaw, CEO of GOSH, said: "What we are building together will strengthen pediatric health systems for the future by leveraging expertise in clinical care, research, data and innovation, and education and training."

Statistics:

  • The partnership will cover multiple areas of collaboration, including clinical service, research, and education in children's health.
  • The agreement will facilitate access to advanced laboratory testing for specialized care of children with complex conditions, including genetic disorders and rare diseases.
  • The partnership aims to drive progress in personalized pediatric medicine through joint capabilities in clinical trial design and implementation.
  • Sidra Medicine will roll out education and skills exchange initiatives for healthcare professionals, including international fellowships and training programs.
  • The partnership is expected to support the development of region-specific diagnostic tools and clinical trials.

Sources:

  • "Qatar News Agency: Sidra Medicine signs MoU with Great Ormond Street Hospital for Children NHS Foundation Trust". (Qatar News Agency, 13 May 2025)
  • "Great Ormond Street Hospital: Press Release: New Partnership to Enhance Pediatric Care and Innovation". (Great Ormond Street Hospital, 13 May 2025)
  • "Sidra Medicine: Press Release: Collaboration with Great Ormond Street Hospital to Advance Pediatric Care and Innovation". (Sidra Medicine, 13 May 2025)